Stocktoria
Cingulate Inc. CING
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-10-07
Cingulate Inc. statistics & valuation
Market cap$66.8M
P / B26.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -148.9% | -111.4% | -674.1% | -155.0% | -90.5% |
| Return on equity | -894.8% | -222.1% | 342.6% | -455.3% | -99.4% |
| Current ratio | 1.16 | 2.55 | 0.06 | 1.12 | 16.05 |
Source: SEC EDGAR filings · CIK 0001862150 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.